Four leading research institutions, including Weill Cornell Medicine, have united under the Weill Cancer Hub East, an innovative, collaborative partnership that aims to transform cancer treatment.
A study from Cornell researchers could enable a quantum leap forward in identifying and deciphering cancer-driving genetic mutations, the first step in developing effective therapeutics.
Cornell researchers have confirmed that a previously identified biomarker for detecting malignant testicular germ cell tumors – the most common solid cancers in young men – has the potential to improve patient outcomes through early detection.
The Class of 2025 learned on March 21 where they will be doing their internship and residency training – setting the stage for the next several years of their medical careers and lives.
Weill Cornell Medicine researchers found that restricting telehealth prescriptions for opioid use disorder could keep thousands from accessing buprenorphine, a medication that helps people recover from addiction.
Chloe Ahmann, assistant professor of anthropology in the College of Arts and Sciences, is helping local organizers in their quest for environmental justice — and bringing her students along. For this work, Ahmann was named recipient of this year’s Kaplan Family Distinguished Faculty Fellowship.
A person’s “bioenergetic age” – or how youthfully their cells generate energy – might be a key indicator of whether they’re at risk of developing Alzheimer’s disease, new research from Weill Cornell Medicine shows.
